Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders

CNS Neurol Disord Drug Targets. 2024;23(5):638-655. doi: 10.2174/1871527322666230412105711.

Abstract

Anxiety is a common mental illness that affects a large number of people around the world, and its treatment is often based on the use of pharmacological substances such as benzodiazepines, serotonin, and 5-hydroxytyrosine (MAO) neurotransmitters. MAO neurotransmitters levels are deciding factors in the biological effects. This review summarizes the current understanding of the MAO system and its role in the modulation of anxiety-related brain circuits and behavior. The MAO-A polymorphisms have been implicated in the susceptibility to generalized anxiety disorder (GAD) in several investigations. The 5-HT system is involved in a wide range of physiological and behavioral processes, involving anxiety, aggressiveness, stress reactions, and other elements of emotional intensity. Among these, 5-HT, NA, and DA are the traditional 5-HT neurons that govern a range of biological activities, including sleep, alertness, eating, thermoregulation, pains, emotion, and memory, as anticipated considering their broad projection distribution in distinct brain locations. The DNMTs (DNA methyltransferase) protein family, which increasingly leads a prominent role in epigenetics, is connected with lower transcriptional activity and activates DNA methylation. In this paper, we provide an overview of the current state of the art in the elucidation of the brain's complex functions in the regulation of anxiety.

Keywords: Anxiety; epigenetics; mitochondrial dysfunction; monoamine oxidase; oxidative stress.; papez circuit.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anxiety Disorders* / metabolism
  • Brain* / metabolism
  • Humans
  • Monoamine Oxidase* / genetics
  • Monoamine Oxidase* / metabolism

Substances

  • Monoamine Oxidase